HEADER CELL CYCLE 01-APR-21 5S9P TITLE CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX TITLE 2 WITH 9-BENZYL-2-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-7-(2-HYDROXYPROPAN-2- TITLE 3 YL)-9H-CARBAZOLE-4-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B, D, E; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS BROMODOMAIN-CONTAINING PROTEIN 4 ISOFORM LONG, BRD4, BROMODOMAIN KEYWDS 2 CONTAINING PROTEIN 4, CAP, HUNK1, MCAP, MITOTIC CHROMOSOME KEYWDS 3 ASSOCIATED PROTEIN SGC, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 2 17-NOV-21 5S9P 1 JRNL REVDAT 1 29-SEP-21 5S9P 0 JRNL AUTH A.V.GAVAI,D.NORRIS,G.DELUCCA,D.TORTOLANI,J.S.TOKARSKI, JRNL AUTH 2 D.DODD,D.O'MALLEY,Y.ZHAO,C.QUESNELLE,P.GILL,W.VACCARO, JRNL AUTH 3 T.HUYNH,V.AHUJA,W.C.HAN,C.MUSSARI,L.HARIKRISHNAN,M.KAMAU, JRNL AUTH 4 M.POSS,S.SHERIFF,C.YAN,F.MARSILIO,K.MENARD,M.L.WEN, JRNL AUTH 5 R.RAMPULLA,D.R.WU,J.LI,H.ZHANG,P.LI,D.SUN,H.YIP,S.C.TRAEGER, JRNL AUTH 6 Y.ZHANG,A.MATHUR,H.ZHANG,C.HUANG,Z.YANG,A.RANASINGHE, JRNL AUTH 7 G.EVERLOF,N.RAGHAVAN,C.K.TYE,S.WEE,J.T.HUNT,G.VITE, JRNL AUTH 8 R.WESTHOUSE,F.Y.LEE JRNL TITL DISCOVERY AND PRECLINICAL PHARMACOLOGY OF AN ORAL JRNL TITL 2 BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR USING JRNL TITL 3 SCAFFOLD-HOPPING AND STRUCTURE-GUIDED DRUG DESIGN. JRNL REF J.MED.CHEM. V. 64 14247 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34543572 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00625 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 30584 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1539 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.17 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2925 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2090 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2771 REMARK 3 BIN R VALUE (WORKING SET) : 0.2077 REMARK 3 BIN FREE R VALUE : 0.2297 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.26 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 154 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4277 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.08720 REMARK 3 B22 (A**2) : -5.55380 REMARK 3 B33 (A**2) : 5.64090 REMARK 3 B12 (A**2) : 3.03990 REMARK 3 B13 (A**2) : -0.38200 REMARK 3 B23 (A**2) : -0.01900 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.283 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.255 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.186 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.276 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.193 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4667 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6437 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1571 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 144 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 800 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4667 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 560 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5455 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.97 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.55 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5S9P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-APR-21. REMARK 100 THE DEPOSITION ID IS D_1001404234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30596 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 46.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09900 REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44200 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3MXF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1%(W/V) TRYPTONE, 50MM HEPES, PH 7.0, REMARK 280 20%(W/V) PEG3350, PH 5.6, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 155 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 69 -62.16 -109.03 REMARK 500 VAL B 69 -62.76 -107.91 REMARK 500 VAL D 69 -62.02 -108.75 REMARK 500 HIS E 42 -60.88 -91.04 REMARK 500 VAL E 69 -63.47 -108.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YW4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YW4 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YW4 D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO D 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YW4 E 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO E 302 DBREF 5S9P A 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5S9P B 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5S9P D 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5S9P E 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 5S9P GLY A 41 UNP O60885 EXPRESSION TAG SEQADV 5S9P HIS A 42 UNP O60885 EXPRESSION TAG SEQADV 5S9P MET A 43 UNP O60885 EXPRESSION TAG SEQADV 5S9P GLY B 41 UNP O60885 EXPRESSION TAG SEQADV 5S9P HIS B 42 UNP O60885 EXPRESSION TAG SEQADV 5S9P MET B 43 UNP O60885 EXPRESSION TAG SEQADV 5S9P GLY D 41 UNP O60885 EXPRESSION TAG SEQADV 5S9P HIS D 42 UNP O60885 EXPRESSION TAG SEQADV 5S9P MET D 43 UNP O60885 EXPRESSION TAG SEQADV 5S9P GLY E 41 UNP O60885 EXPRESSION TAG SEQADV 5S9P HIS E 42 UNP O60885 EXPRESSION TAG SEQADV 5S9P MET E 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 128 GLY HIS MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 2 A 128 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 3 A 128 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 4 A 128 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 5 A 128 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 6 A 128 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 7 A 128 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 8 A 128 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 9 A 128 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 10 A 128 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 B 128 GLY HIS MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 2 B 128 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 3 B 128 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 4 B 128 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 5 B 128 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 6 B 128 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 7 B 128 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 8 B 128 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 9 B 128 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 10 B 128 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 D 128 GLY HIS MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 2 D 128 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 3 D 128 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 4 D 128 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 5 D 128 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 6 D 128 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 7 D 128 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 8 D 128 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 9 D 128 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 10 D 128 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 E 128 GLY HIS MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 2 E 128 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 3 E 128 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 4 E 128 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 5 E 128 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 6 E 128 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 7 E 128 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 8 E 128 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 9 E 128 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 10 E 128 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU HET YW4 A 301 61 HET YW4 B 301 61 HET YW4 D 301 61 HET EDO D 302 4 HET YW4 E 301 61 HET EDO E 302 4 HETNAM YW4 9-BENZYL-2-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-7-(2- HETNAM 2 YW4 HYDROXYPROPAN-2-YL)-9H-CARBAZOLE-4-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 YW4 4(C28 H27 N3 O3) FORMUL 8 EDO 2(C2 H6 O2) FORMUL 11 HOH *141(H2 O) HELIX 1 AA1 THR A 60 VAL A 69 1 10 HELIX 2 AA2 VAL A 69 HIS A 77 1 9 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 116 1 11 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 GLU A 163 1 20 HELIX 8 AA8 THR B 60 VAL B 69 1 10 HELIX 9 AA9 VAL B 69 HIS B 77 1 9 HELIX 10 AB1 ALA B 80 GLN B 84 5 5 HELIX 11 AB2 ASP B 88 ASN B 93 1 6 HELIX 12 AB3 ASP B 96 ILE B 101 1 6 HELIX 13 AB4 ASP B 106 ASN B 116 1 11 HELIX 14 AB5 ASN B 121 ASN B 140 1 20 HELIX 15 AB6 ASP B 144 GLU B 163 1 20 HELIX 16 AB7 THR D 60 VAL D 69 1 10 HELIX 17 AB8 VAL D 69 HIS D 77 1 9 HELIX 18 AB9 ALA D 80 GLN D 84 5 5 HELIX 19 AC1 ASP D 96 ILE D 101 1 6 HELIX 20 AC2 ASP D 106 ASN D 116 1 11 HELIX 21 AC3 ASN D 121 ASN D 140 1 20 HELIX 22 AC4 ASP D 144 GLU D 163 1 20 HELIX 23 AC5 THR E 60 VAL E 69 1 10 HELIX 24 AC6 VAL E 69 HIS E 77 1 9 HELIX 25 AC7 ALA E 80 GLN E 84 5 5 HELIX 26 AC8 ASP E 96 ILE E 101 1 6 HELIX 27 AC9 ASP E 106 ASN E 116 1 11 HELIX 28 AD1 ASN E 121 ASN E 140 1 20 HELIX 29 AD2 ASP E 144 GLU E 163 1 20 CISPEP 1 GLY A 41 HIS A 42 0 -7.76 CISPEP 2 GLY B 41 HIS B 42 0 -14.88 CISPEP 3 GLY D 41 HIS D 42 0 -7.44 CISPEP 4 GLY E 41 HIS E 42 0 -12.11 SITE 1 AC1 13 TRP A 81 PRO A 82 PHE A 83 GLN A 85 SITE 2 AC1 13 PRO A 86 ASP A 88 LEU A 92 ASN A 140 SITE 3 AC1 13 MET A 149 HOH A 402 GLN D 78 PHE D 79 SITE 4 AC1 13 ASP D 145 SITE 1 AC2 15 TRP B 81 PRO B 82 PHE B 83 GLN B 85 SITE 2 AC2 15 PRO B 86 ASP B 88 LEU B 92 ASN B 140 SITE 3 AC2 15 ILE B 146 HOH B 401 HIS E 77 GLN E 78 SITE 4 AC2 15 PHE E 79 LEU E 148 HOH E 412 SITE 1 AC3 10 TRP D 81 PRO D 82 PHE D 83 GLN D 85 SITE 2 AC3 10 PRO D 86 ASP D 88 LEU D 92 ASN D 140 SITE 3 AC3 10 MET D 149 HOH D 402 SITE 1 AC4 6 ILE D 100 LYS D 102 THR D 103 ASN D 135 SITE 2 AC4 6 HOH D 411 ASN E 116 SITE 1 AC5 11 TRP E 81 PRO E 82 PHE E 83 GLN E 85 SITE 2 AC5 11 PRO E 86 ASP E 88 LEU E 92 ASN E 140 SITE 3 AC5 11 ILE E 146 MET E 149 HOH E 402 SITE 1 AC6 5 HOH D 410 TRP E 75 HIS E 77 GLN E 84 SITE 2 AC6 5 HOH E 424 CRYST1 42.131 58.063 59.586 104.20 90.32 98.47 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023735 0.003535 0.001045 0.00000 SCALE2 0.000000 0.017413 0.004474 0.00000 SCALE3 0.000000 0.000000 0.017328 0.00000